Home Duke University Press
 QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Neuro Oncol 2000 2(3):184-189; DOI:10.1215/15228517-2-3-184
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dam, A.
Right arrow Articles by van den Berg, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Duke University Press

Pediatric Neuro-Oncology

Recurrent astrocytoma in a child: A report of cytogenetics and TP53 gene mutation screening

Anke Dam, Johanna M. Fock, Vanessa M. Hayes, Willemina M. Molenaar2 and Eva van den Berg

Departments of Pathology (A.D., W.M.M.), Child Neurology (J.M.F.), and Medical Genetics (E.v.d.B., V.M.H.), University Hospital of Groningen, The Netherlands

2 Address correspondence and reprint requests to W.M. Molenaar, Department of Pathology, University Hospital of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.

Abstract

An 8-year-old girl presented with a cerebral tumor and 3 recurrences within 15 months. The primary tumor was a low-grade astrocytoma, but the recurrences showed progressively malignant phenotypes with increasing mitotic activity and MIB-1 labeling indices. Radiotherapy was given between the first and the second recurrences. Cytogenetic analysis of the first and the second recurrences showed abnormal karyotypes. There seemed to be 2 common breakpoints in these 2 recurrences. TP53 gene mutation screening, using comprehensive denaturing gradient gel electrophoresis, revealed among others a possibly causative mutation of exon 5 in 3 of 4 tumor samples. The meaning of TP53 mutations in low-grade astrocytomas is still unclear, but the highly abnormal karyotypes, which are unusual in these tumors, probably provide genetic evidence for the unexpected aggressive behavior of the tumor in this patient.







  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Copyright 2000 by Society for Neuro-Oncology